How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,098 results for

Defensive Medicine

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

5061. Intestinal Microvascular Endothelium and Innate Immunity in Inflammatory Bowel Disease: a Second Line of Defense? (PubMed)

Intestinal Microvascular Endothelium and Innate Immunity in Inflammatory Bowel Disease: a Second Line of Defense? 16988217 2006 11 28 2018 11 13 0019-9567 74 10 2006 Oct Infection and immunity Infect. Immun. Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense? 5425-32 Heidemann Jan J Department of Medicine B, University of Münster, Albert-Schweitzer-Str. 33, D-48129 Münster, Germany. Jan_Heidemann@hotmail.com Domschke Wolfram W

Full Text available with Trip Pro

2006 Infection and immunity

5062. Aspergillus fumigatus: Principles of Pathogenesis and Host Defense (PubMed)

Aspergillus fumigatus: Principles of Pathogenesis and Host Defense 17890370 2008 01 10 2019 01 08 1535-9778 6 11 2007 Nov Eukaryotic cell Eukaryotic Cell Aspergillus fumigatus: principles of pathogenesis and host defense. 1953-63 Hohl Tobias M TM Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA. hohlt@mskcc.org Feldmesser Marta M eng R01 AI059663 AI NIAID NIH HHS United States R01AI059663 AI NIAID NIH HHS United

Full Text available with Trip Pro

2007 Eukaryotic cell

5063. The Insanity Defense (PubMed)

The Insanity Defense 21120104 2011 07 14 2010 12 01 1550-5952 2 9 2005 Sep Psychiatry (Edgmont (Pa. : Township)) Psychiatry (Edgmont) The insanity defense. 24-5 Feuerstein Seth S All authors are from Yale University School of Medicine, New Haven, Connecticut. Fortunati Frank F Morgan Charles A CA Coric Vladimir V Temporini Humberto H Southwick Steven S eng Journal Article United States Psychiatry (Edgmont) 101484252 1550-5952 2010 12 2 6 0 2005 9 1 0 0 2005 9 1 0 1 ppublish 21120104 PMC2993532

Full Text available with Trip Pro

2005 Psychiatry (Edgmont)

5064. Epidemiological Study of HIV in the South African National Defense Force

Epidemiological Study of HIV in the South African National Defense Force Epidemiological Study of HIV in the South African National Defense Force - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Epidemiological Study of HIV in the South African National Defense Force The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00341887 Recruitment Status : Terminated First Posted : June 21, 2006 Last Update Posted : April 3, 2019 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Information

2006 Clinical Trials

5065. NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD

NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00180635 Recruitment Status : Completed First Posted : September 16, 2005 Last Update Posted : June 4, 2015 Sponsor

2005 Clinical Trials

5066. Breast MRI Spectroscopy, Department of Defense (DOD)

of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00582569 Locations Layout table for location information United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Sponsors and Collaborators Memorial Sloan Kettering Cancer Center United States Department of Defense (...) Breast MRI Spectroscopy, Department of Defense (DOD) Breast MRI Spectroscopy, Department of Defense (DOD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Breast MRI Spectroscopy, Department of Defense (DOD

2007 Clinical Trials

5067. Esophageal Motility and Airway Defenses Among Infants

Esophageal Motility and Airway Defenses Among Infants Esophageal Motility and Airway Defenses Among Infants - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Esophageal Motility and Airway Defenses Among (...) measurements in this evaluation. Study Design Go to Layout table for study information Study Type : Observational Actual Enrollment : 65 participants Observational Model: Cohort Time Perspective: Prospective Official Title: Esophageal Motility and Airway Defenses Among Infants Study Start Date : May 2002 Actual Primary Completion Date : April 2005 Actual Study Completion Date : July 2005 Groups and Cohorts Go to Group/Cohort A-1,2,3 The cohort (A) comprised of high risk infants. There were 3 sub groups

2003 Clinical Trials

5068. Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus

of Antimicrobial Peptides in Host Defense Against Vaccinia Virus (ADVN AMP01) Study Start Date : June 2005 Actual Primary Completion Date : February 2010 Actual Study Completion Date : February 2010 Resource links provided by the National Library of Medicine related topics: related topics: Groups and Cohorts Go to Group/Cohort Active Atopic Dermatitis (AD) Pediatric and adult subjects who fulfill the criteria for AD, a chronic inflammatory skin disease. Inactive Atopic Dermatitis (AD) Adult subjects (...) Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Role

2006 Clinical Trials

5069. Guidelines abstracted from the Department of Veterans Affairs/Department of Defense clinical practice guideline for the management of stroke rehabilitation. (PubMed)

Guidelines abstracted from the Department of Veterans Affairs/Department of Defense clinical practice guideline for the management of stroke rehabilitation. To assist facilities in identifying those evidence-based processes of poststroke care that enhance measurable patient outcomes. The guideline(s) should be used by facilities (hospitals, subacute-care units and providers of long-term care) to implement a structured approach to improve rehabilitative practices and by clinicians to determine (...) for poststroke managements are presented separately.The overall guideline considers improvement in functional status measures as the primary outcome. Achieving community-dwelling status and preventing complications, death, and rehospitalization are also important outcomes. Costs are not specifically addressed.The Department of Veterans Affairs/Department of Defense (VA/DoD) Stroke Rehabilitation Working Group consisted of 28, largely VA and military hospital, representatives of medical and allied professions

2006 Journal of the American Geriatrics Society

5070. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. (PubMed)

Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. Polycystic ovary syndrome (PCOS) is a very common endocrinopathy with a heterogeneous presentation whose etiology is still uncertain. Not surprisingly, therefore, the definition of, and diagnostic criteria for, PCOS remain controversial.The objective of the study was to review and justify the basis for the recently revised definition of PCOS arising from the joint European (...) Society for Human Reproduction & Embryology/American Society for Reproductive Medicine (ESHRE/ASRM) Rotterdam workshop in 2003.The Rotterdam criteria take account of the broad spectrum of presenting features of PCOS, including women with hyperandrogenism but regular menses and, more controversially, those with menstrual disturbance without overt androgen excess. POSITIONS: The Rotterdam criteria for definition and diagnosis of PCOS, in the opinion of this author, represent a significant advance

Full Text available with Trip Pro

2006 Journal of Clinical Endocrinology and Metabolism

5071. Effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on disruption of hepatic antioxidant defense systems in rats treated with D-galactosamine. (PubMed)

Effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on disruption of hepatic antioxidant defense systems in rats treated with D-galactosamine. We have indicated that the antioxidant action of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract (TJ-15), a traditional Chinese herbal medicine, may contribute to its preventive effect on the progression of D-galactosamine (GAL)-induced liver injury in rats. Herein, we examined a possibility that TJ-15 exerts this preventive effect by attenuating (...) the disruption of hepatic antioxidant defense systems in GAL-treated rats. TJ-15 (500 mg/kg) was orally administered to rats injected with GAL (500 mg/kg, i.p.) at 6 h after hepatotoxin treatment. In the liver of rats treated with GAL alone, the concentration of thiobarbituric acid-reactive substances (TBARS), an index of lipid peroxidation, increased at 24 h, but not at 6 h, while reduced glutathione (GSH) and ascorbic acid concentrations and superoxide dismutase (SOD), catalase, and Se-glutathione

2004 Journal of Ethnopharmacology

5072. Acting in Defense of the Medical Literature (PubMed)

Acting in Defense of the Medical Literature 15208550 2006 05 18 2018 11 13 1531-0132 6 1 2004 Mar 24 MedGenMed : Medscape general medicine MedGenMed Acting in defense of the medical literature. 38 Katz David L DL eng Comment Letter 2004 03 24 United States MedGenMed 100894134 1531-0132 IM MedGenMed. 2003 Dec 30;5(4):39 14745386 MedGenMed. 2004;6(1):33 15208545 Ethics Ethics, Medical Evidence-Based Medicine ethics Naturopathy Periodicals as Topic ethics Practice Patterns, Physicians' ethics

Full Text available with Trip Pro

2004 Medscape General Medicine

5073. Pulmonary surfactant: a front line of lung host defense (PubMed)

Pulmonary surfactant: a front line of lung host defense 12750392 2003 06 04 2018 11 13 0021-9738 111 10 2003 May The Journal of clinical investigation J. Clin. Invest. Pulmonary surfactant: a front line of lung host defense. 1453-5 Wright Jo Rae JR Department of Cell Biology, Duke University School Of Medicine, Durham, North Carolina 27710, USA. j.wright@cellbio.duke.edu eng HL-30923 HL NHLBI NIH HHS United States R01 HL068072 HL NHLBI NIH HHS United States R01 HL030923 HL NHLBI NIH HHS United

Full Text available with Trip Pro

2003 Journal of Clinical Investigation

5074. Will Spam Overwhelm Our Defenses? Evaluating Offerings for Drugs and Natural Health Products (PubMed)

Will Spam Overwhelm Our Defenses? Evaluating Offerings for Drugs and Natural Health Products 17880258 2007 11 20 2018 11 13 1549-1676 4 9 2007 Sep PLoS medicine PLoS Med. Will spam overwhelm our defenses? Evaluating offerings for drugs and natural health products. e274 Gernburd Peter P Centre for Global eHealth Innovation, University Health Network and University of Toronto, Toronto, Ontario, Canada. ajadad@ehealthinnovation.org Jadad Alejandro R AR eng Comparative Study Evaluation Studies

Full Text available with Trip Pro

2007 PLoS medicine

5075. How to leverage an endogenous immune defense mechanism: the example of granulocyte colony-stimulating factor. (PubMed)

How to leverage an endogenous immune defense mechanism: the example of granulocyte colony-stimulating factor. Our understanding of host defense has exploded during the past two decades. It is temping to take advantage of this knowledge by considering the modulation and control of these mechanisms as therapeutic options. In intensive care medicine, the aim is usually to block an overwhelming inflammatory response, which represents the "bad" side of the double-edged sword of host defense (...) . The obvious danger of such treatment strategies is that impairing the inflammatory reaction means impairing host defense in patients exposed to infectious agents. The alternative approach, i.e., strengthening or supplementing favorable host defense mechanism, has so far been little explored clinically. Granulocyte colony-stimulating factor, the granulocyte colony-stimulating factor, combines the unique properties of an anti-infectious and an anti-inflammatory factor. This attractive profile has led us

2003 Critical care medicine Controlled trial quality: uncertain

5076. Doctors' estimation of cardiovascular risk and willingness to give drug treatment in hypertension: fair risk assessment but defensive treatment policy. (PubMed)

Doctors' estimation of cardiovascular risk and willingness to give drug treatment in hypertension: fair risk assessment but defensive treatment policy. We studied the differences between recommendations given in the 1999 World Health Organization-International Society of Hypertension (WHO/ISH) Guidelines and doctors' risk estimation and willingness to give antihypertensive drugs.A population-based sample, the WHO Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (WHO (...) MONICA) (n = 5997), was classified according to the 1999 WHO/ISH Hypertension Guidelines risk stratification scheme. A total of 54 subjects were randomly drawn from the 12 different risk categories. Written case stories were constructed based on risk-factor levels for each selected subject.Doctors (n = 139), comprising general practitioners (GPs, n = 110) and specialists in internal medicine or cardiology (specialists, n = 29), in northern Sweden assessed 12 cases each.Factors used in risk assessment

2004 Journal of hypertension Controlled trial quality: uncertain

5077. Host defenses against infection: importance of phagocytic mechanisms from the study of genetic disorders of leukocyte function. (PubMed)

Host defenses against infection: importance of phagocytic mechanisms from the study of genetic disorders of leukocyte function. 6301588 1983 06 10 2018 11 13 0028-7091 58 8 1982 Nov Bulletin of the New York Academy of Medicine Bull N Y Acad Med Host defenses against infection: importance of phagocytic mechanisms from the study of genetic disorders of leukocyte function. 669-80 Root R K RK eng Journal Article Research Support, Non-U.S. Gov't Review United States Bull N Y Acad Med 7505398 0028 (...) (4):668-79 6021213 Infect Immun. 1971 Jun;3(6):800-2 16558057 J Bacteriol. 1967 Nov;94(5):1425-30 4964478 Blood. 1969 Jun;33(6):813-20 4890921 Rev Infect Dis. 1980 Jan-Feb;2(1):106-28 6994199 Biochemistry. 1981 Mar 17;20(6):1468-76 6261795 J Clin Invest. 1975 May;55(5):945-55 1123431 N Engl J Med. 1980 May 22;302(21):1163-8 7366657 Medicine (Baltimore). 1972 Jul;51(4):247-80 5064229 Science. 1966 Nov 25;154(3752):1049-51 4958495 N Engl J Med. 1981 Nov 26;305(22):1329-33 6270561 N Engl J Med. 1980

Full Text available with Trip Pro

1982 Bulletin of the New York Academy of Medicine

5078. In Defense of the Bladder (PubMed)

In Defense of the Bladder 18749202 2010 06 30 2018 11 13 0093-0415 137 3 1982 Sep The Western journal of medicine West. J. Med. In defense of the bladder. 237-9 Kunin C M CM Department of Medicine, The Ohio State University, Columbus. eng Journal Article United States West J Med 0410504 0093-0415 1982 9 1 0 0 1982 9 1 0 1 1982 9 1 0 0 ppublish 18749202 PMC1274082 J Clin Invest. 1968 Dec;47(12):2689-700 4881768 Lancet. 1980 Apr 19;1(8173):887 6103253 Lancet. 1981 Aug 22;2(8243):393-6 6115160

Full Text available with Trip Pro

1982 Western Journal of Medicine

5079. Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation. (PubMed)

Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation. 1541544 1992 04 03 2018 11 13 0019-9567 60 3 1992 Mar Infection and immunity Infect. Immun. Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation. 721-7 Horstmann R D RD Bernhard Nocht Institute for Tropical Medicine, Hamburg

Full Text available with Trip Pro

1992 Infection and immunity

5080. HSV.com: Maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense (PubMed)

HSV.com: Maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense 10823927 2000 06 30 2018 11 13 0027-8424 97 11 2000 May 23 Proceedings of the National Academy of Sciences of the United States of America Proc. Natl. Acad. Sci. U.S.A. HSV.com: maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense. 5684-6 Tan S L SL Department of Microbiology, School of Medicine, Box 357242, and Regional Primate Research Center, Box 357330

Full Text available with Trip Pro

2000 Proceedings of the National Academy of Sciences of the United States of America

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>